Based in Kentfield in Marin County, Alix Alderman is a respected presence in the Northern California pharmaceutical and biotechnology therapeutic development sphere. Kentfield professional Alix Alderman serves PellePharm, a BridgeBio company, where her executive focus is on global regulatory intelligence, global development and market access strategies to accelerate a dermatologic oncology NCE drug to patients. She also has experience in achieving regulatory and market pathways for innovative medications that do not have regulatory precedent.

Ms. Alderman attended the University of California, Davis, earning a BS in kinesiology. Co-captaining the women's gymnastics team, she earned an Outstanding Student-Athlete award.

Ms. Alderman began her work in the pharmaceutical sphere in 2001 with InterMune, Inc., and rose from an associate position to lead global regulatory strategy and global product strategy for novel rare disease therapeutics at InterMune, Amylin, AbbVie, and Ultragenyx. Among her achievements were guiding negotiations with the Food and Drug Administration, Health Canada, EMA and global health authorities, and the related submission of documentation spanning new INDs, CTAs, NDAs, BLAs and supplements. Active in gymnastics, Alix Alderman enjoys running and hiking in Marin County in her free time.